CAMBRIDGE, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today
announced that it will present a company overview at the Stifel Healthcare Conference 2016 on Wednesday, November 16, 2016, at
10:15 a.m. ET in New York City.
A live webcast of the presentation will be available on the Investors & Media section of the Editas website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following
the presentation.
About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases
by correcting their disease-causing genes. The company was founded by world leaders in genome editing, and its mission is to
translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest
number of patients.
Media Contact Dan Budwick
Pure Communications, Inc.
(973) 271-6085 dan@purecommunicationsinc.com Investor Contact Mark Mullikin Editas Medicine, Inc. (617) 401-9083 mark.mullikin@editasmed.com
